Researchers, patients, and other stakeholders' perspectives on challenges to and strategies for engagement.

Comparative effectiveness research Engagement challenges Engagement strategies Patient engagement Patient participation Patient-centered research Stakeholder engagement Stakeholder participation

Journal

Research involvement and engagement
ISSN: 2056-7529
Titre abrégé: Res Involv Engagem
Pays: England
ID NLM: 101708164

Informations de publication

Date de publication:
2020
Historique:
received: 19 03 2020
accepted: 04 08 2020
entrez: 12 10 2020
pubmed: 13 10 2020
medline: 13 10 2020
Statut: epublish

Résumé

There is growing interest in patient and stakeholder engagement in research, yet limited evidence about effective methods. Since 2012, the Patient-Centered Outcomes Research Institute (PCORI) has funded patient-centered comparative effectiveness research with a requirement for engaging patients and other stakeholders as research partners in study planning, conduct, and dissemination. This requirement, unique among large healthcare research funders in the US, provides an opportunity to learn about challenges encountered and specific strategies used by PCORI-funded study teams. The primary objective of this study is to describe -- from the perspective of PCORI investigators and research partners-the most common engagement challenges encountered in the first two years of the projects and promising strategies to prevent and overcome these challenges. Descriptive information about investigators, partners, and their engagement was collected from investigators via annual ( Investigators and partners most often described engagement challenges in three domains: (1) infrastructure to support engagement, (2) building relationships, and (3) maintaining relationships. Infrastructure challenges related to financial and human resources, including funding support and dedicated staff, identifying diverse groups of partners, and partners' logistical needs. Challenges for both building and maintaining relationships encompass a variety of aspects of authentic, positive interactions that facilitate mutual understanding, full participation, and genuine influence on the projects. Strategies to prevent or mitigate engagement challenges also corresponded overall to the same three domains. Both groups typically described strategies more generally, with applicability to a range of challenges rather than specific actions to address only particular challenges. Meaningful engagement of patients and other stakeholders comes with challenges, as does any innovation in the research process. The challenges and promising practices identified by these investigators and partners, related to engagement infrastructure and the building and maintenance of relationships, reveal actionable areas to improve engagement, including organizational policies and resources, training, new engagement models, and supporting engagement by viewing it as an investment in research uptake and impact.

Sections du résumé

BACKGROUND BACKGROUND
There is growing interest in patient and stakeholder engagement in research, yet limited evidence about effective methods. Since 2012, the Patient-Centered Outcomes Research Institute (PCORI) has funded patient-centered comparative effectiveness research with a requirement for engaging patients and other stakeholders as research partners in study planning, conduct, and dissemination. This requirement, unique among large healthcare research funders in the US, provides an opportunity to learn about challenges encountered and specific strategies used by PCORI-funded study teams. The primary objective of this study is to describe -- from the perspective of PCORI investigators and research partners-the most common engagement challenges encountered in the first two years of the projects and promising strategies to prevent and overcome these challenges.
METHODS METHODS
Descriptive information about investigators, partners, and their engagement was collected from investigators via annual (
RESULTS RESULTS
Investigators and partners most often described engagement challenges in three domains: (1) infrastructure to support engagement, (2) building relationships, and (3) maintaining relationships. Infrastructure challenges related to financial and human resources, including funding support and dedicated staff, identifying diverse groups of partners, and partners' logistical needs. Challenges for both building and maintaining relationships encompass a variety of aspects of authentic, positive interactions that facilitate mutual understanding, full participation, and genuine influence on the projects. Strategies to prevent or mitigate engagement challenges also corresponded overall to the same three domains. Both groups typically described strategies more generally, with applicability to a range of challenges rather than specific actions to address only particular challenges.
CONCLUSION CONCLUSIONS
Meaningful engagement of patients and other stakeholders comes with challenges, as does any innovation in the research process. The challenges and promising practices identified by these investigators and partners, related to engagement infrastructure and the building and maintenance of relationships, reveal actionable areas to improve engagement, including organizational policies and resources, training, new engagement models, and supporting engagement by viewing it as an investment in research uptake and impact.

Identifiants

pubmed: 33042576
doi: 10.1186/s40900-020-00227-0
pii: 227
pmc: PMC7539495
doi:

Types de publication

Journal Article

Langues

eng

Pagination

60

Informations de copyright

© The Author(s) 2020.

Déclaration de conflit d'intérêts

Competing interestsThe authors declare that they have no competing interests.

Références

J Eval Clin Pract. 2018 Feb;24(1):240-253
pubmed: 29076631
BMC Health Serv Res. 2014 Feb 26;14:89
pubmed: 24568690
Health Aff (Millwood). 2019 Mar;38(3):359-367
pubmed: 30830822
Qual Life Res. 2018 Jan;27(1):17-31
pubmed: 28500572
Health Serv Res. 1999 Dec;34(5 Pt 2):1189-208
pubmed: 10591279
Prog Community Health Partnersh. 2017;11(3):243-251
pubmed: 29056616
AJOB Empir Bioeth. 2017 Jan-Mar;8(1):1-10
pubmed: 28949867
J Gen Intern Med. 2016 Jan;31(1):13-21
pubmed: 26160480
Res Involv Engagem. 2018 May 22;4:17
pubmed: 29796308
Arthritis Rheum. 2006 Aug 15;55(4):676-80
pubmed: 16874772
J Gen Intern Med. 2014 Dec;29(12):1692-701
pubmed: 24893581
JAMA. 2014 Aug 6;312(5):483-4
pubmed: 24911291
Health Serv Res. 2007 Aug;42(4):1758-72
pubmed: 17286625
J Comp Eff Res. 2015 Jan;4(1):11-25
pubmed: 25565066
J Gen Intern Med. 2012 Aug;27(8):985-91
pubmed: 22528615
Health Aff (Millwood). 2013 Feb;32(2):223-31
pubmed: 23381514
Ann Fam Med. 2017 Mar;15(2):165-170
pubmed: 28289118
Patient. 2014;7(4):387-95
pubmed: 25034612
Qual Life Res. 2015 May;24(5):1033-41
pubmed: 25560774
Patient Prefer Adherence. 2017 Sep 13;11:1573-1583
pubmed: 28979105
J Clin Transl Sci. 2017 Apr;1(2):121-128
pubmed: 28649454
J Gen Intern Med. 2018 Apr;33(4):558-562
pubmed: 29327211
Nurs Health Sci. 2013 Sep;15(3):398-405
pubmed: 23480423
Patient Educ Couns. 2017 Jan;100(1):25-29
pubmed: 27473639
Health Res Policy Syst. 2018 Feb 7;16(1):5
pubmed: 29415734
Perm J. 2018 Jun 6;22:17-232
pubmed: 29911967
BMJ Open. 2018 Mar 23;8(3):e020452
pubmed: 29572398
Res Involv Engagem. 2017 Jan 9;3:1
pubmed: 29062526
Health Expect. 2014 Oct;17(5):637-50
pubmed: 22809132
Res Involv Engagem. 2016 Feb 22;2:6
pubmed: 29062507
JAMA Surg. 2016 May 1;151(5):408-15
pubmed: 26676711
Health Expect. 2011 Dec;14(4):439-48
pubmed: 21176014
Health Technol Assess. 2004 Apr;8(15):1-148, III-IV
pubmed: 15080866
Med Decis Making. 2011 Nov-Dec;31(6):E45-74
pubmed: 21959267
BMC Endocr Disord. 2017 Jul 24;17(1):46
pubmed: 28738902

Auteurs

Andrea Heckert (A)

Present Address, Independent Consultant, Portland, OR USA.
Evaluation & Analysis, Patient-Centered Outcomes Research Institute, 1828 L St NW, Suite 900, Washington, DC 20036 USA.

Laura P Forsythe (LP)

Evaluation & Analysis, Patient-Centered Outcomes Research Institute, 1828 L St NW, Suite 900, Washington, DC 20036 USA.

Kristin L Carman (KL)

Public and Patient Engagement, Patient-Centered Outcomes Research Institute, Washington, DC 20036 USA.

Lori Frank (L)

RAND, Arlington, VA 22202 USA.

Rachel Hemphill (R)

Evaluation & Analysis, Patient-Centered Outcomes Research Institute, 1828 L St NW, Suite 900, Washington, DC 20036 USA.

Emily A Elstad (EA)

American Institutes for Research, Chapel Hill, NC 27517 USA.

Laura Esmail (L)

Present Address, Independent Consultant, Paris, France.
Clinical Effectiveness and Decision Science, Patient-Centered Outcomes Research Institute, 1828 L St NW, Suite 900, Washington, DC, USA.

Julie Kennedy Lesch (JK)

Public and Patient Engagement, Patient-Centered Outcomes Research Institute, Washington, DC 20036 USA.

Classifications MeSH